Veterans Health Administration Novel Therapeutics Preparedness Act
Sen. Sheehy Introduces Bipartisan Bill to Prepare VA for Psychedelic and Novel Mental Health Therapies
This bill is currently in the early stages of the legislative process after being sent to the Senate Committee on Veterans' Affairs for review. It is considered active, but there are no upcoming votes or hearings scheduled at this time. The bill is waiting for the committee to decide if it should move forward for further consideration.
Legislative Progress
The bill has strong bipartisan support and addresses the high-priority issue of veteran mental health, though creating a new office and coordinating multiple agencies takes time.
Key Points
Impact Analysis
Personal Impact
Life & Work
VA clinicians and peer support specialists would receive new training opportunities and credentialing pathways for emerging therapies. The bill also protects research time by counting patients seen under approved research protocols toward clinical productivity metrics, reducing a common barrier that discourages VA clinicians from participating in research.
“patients seen under approved research protocols shall be counted toward standard clinical productivity metrics”
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Veterans' Affairs.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
4 articles
'Major Step': New Law Would Prep VA for FDA-Approved Psychedelic Treatments
Bipartisan legislation (SB 4220) would require the VA to evaluate and implement emerging mental health treatments, including psychedelics. It establishes an Office of Novel Therapeutics to oversee clinical standards, workforce readiness, and infrastructure for therapies like MDMA and psilocybin.
Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans
Senators introduced the Veterans Health Administration Novel Therapeutics Preparedness Act to create a new VA office for innovative treatments. The bill aims to streamline research into psychedelics for PTSD and depression, establishing regional Centers of Excellence to lead implementation.
Duckworth, Sheehy Introduce Bipartisan Bill to Increase Access to Innovative Veteran Health Care
Senators Tammy Duckworth and Tim Sheehy introduced a bill to create a VA Office of Novel Therapeutics. The office would set national clinical standards and training for emerging therapies, ensuring the VA is prepared to offer innovative care for invisible wounds like PTSD and depression.
Source Information
Document Type
Congressional Bill
Official Title
Veterans Health Administration Novel Therapeutics Preparedness Act
Data Sources
Sponsor
Cosponsors
(3)Analysis generated by AI. Always verify with official sources.